On this page you will find any clinical guidance and treatment pathways that have been approved by GMMMG or its Subgroups.
Documents are listed alphabetically.
The ‘Document Title’, ‘Issue Date’ and ‘Review Date’ headings below are active links. Click a heading to sort in ascending or descending order.
|Document Title||Issue Date||Review Date||Status|
|Engagement with the Pharmaceutical Industry||20171228 Dec 2017||20201228 Dec 2020|
|GMMMG Appeals Policy||20171228 Dec 2017||20201228 Dec 2020|
|GMMMG Declaration of interests - form||20160928 Sep 2016||20190928 Sep 2019|
|GMMMG Declaration of interests - policy||20160928 Sep 2016||20190928 Sep 2019|
|Guidelines for defining Red, Amber, Green, DNP and Grey status||20210828 Aug 2021|
|High cost drug business case template||20131028 Oct 2013|
|High cost drugs service development guideline||20131028 Oct 2013|
|Management of Red Listed drugs in primary care||20190428 Apr 2019||20220428 Apr 2022|
|Primary care rebate schemes|